Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q1 2026 vs. Q4 2025
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 25.4K | 0 | −25.4K (−100.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (1)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Garton & Associates Financial Advisors LLC | 25,354 | $0 |